ACME Laboratories (DHA:ACMELAB) E10: BDT10.32 (As of Mar. 2026)


DHA:ACMELAB ACME Laboratories Ltd DHA:ACMELAB
82 GF Score
Price BDT81.60
GF Value BDT124.74
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is ACME Laboratories E10?

ACME Laboratories DHA:ACMELAB +0.37% 82 E10 is BDT10.32 as of Mar. 2026. GuruFocus rates DHA:ACMELAB with a GF Score™ of 82/100 and a GF Value™ of BDT124.74 (Possible Value Trap). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

ACME Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was BDT3.300. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is BDT10.32 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-29), ACME Laboratories's current stock price is BDT81.60. ACME Laboratories's E10 for the quarter that ended in Mar. 2026 was BDT10.32. ACME Laboratories's Shiller PE Ratio of today is 7.91.

During the past 9 years, the highest Shiller PE Ratio of ACME Laboratories was 8.14. The lowest was 7.23. And the median was 7.45.


ACME Laboratories  (DHA:ACMELAB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

ACME Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=81.60/10.32
=7.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 9 years, the highest Shiller P/E Ratio of ACME Laboratories was 8.14. The lowest was 7.23. And the median was 7.45.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


ACME Laboratories E10 Related Terms


ACME Laboratories E10 Historical Data

* Premium members only.

The historical data trend for ACME Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ACME Laboratories E10 Chart

ACME Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
E10
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

ACME Laboratories Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 9.96 10.32

DHA:ACMELAB vs ZTS, UTHR, VTRS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ACME Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACME Laboratories Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ACME Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ACME Laboratories's Shiller PE Ratio falls into.


DHA:ACMELAB
82GF Score
ACME Laboratories Ltd DHA:ACMELAB
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ACME Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ACME Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.3/330.2130*330.2130
=3.300

Current CPI (Mar. 2026) = 330.2130.

ACME Laboratories Quarterly Data

per share eps CPI Adj_EPS
201603 1.181 238.132 1.638
201606 0.000 241.018 0.000
201609 1.790 241.428 2.448
201612 1.810 241.432 2.476
201703 1.820 243.801 2.465
201706 1.189 244.955 1.603
201709 1.990 246.819 2.662
201712 1.820 246.524 2.438
201803 1.850 249.554 2.448
201806 1.080 251.989 1.415
201809 1.840 252.439 2.407
201812 1.850 251.233 2.432
201903 1.740 254.202 2.260
201906 1.380 256.143 1.779
201909 1.890 256.759 2.431
201912 1.770 256.974 2.274
202003 1.680 258.115 2.149
202006 1.510 257.797 1.934
202009 1.960 260.280 2.487
202012 1.780 260.474 2.257
202103 1.840 264.877 2.294
202106 1.830 271.696 2.224
202109 2.770 274.310 3.335
202112 2.400 278.802 2.843
202203 2.380 287.504 2.734
202206 2.430 296.311 2.708
202209 2.930 296.808 3.260
202212 2.520 296.797 2.804
202303 2.530 301.836 2.768
202306 2.905 305.109 3.144
202309 3.110 307.789 3.337
202312 2.670 306.746 2.874
202403 2.750 312.332 2.907
202406 3.074 314.175 3.231
202409 2.610 315.301 2.733
202412 2.860 315.605 2.992
202503 2.810 319.799 2.902
202509 3.010 324.800 3.060
202512 3.100 324.054 3.159
202603 3.300 330.213 3.300

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of BDT10.32 mean?
ACME Laboratories (DHA:ACMELAB) has a E10 of BDT10.32 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on ACME Laboratories and its competitors.
Is ACME Laboratories' E10 too high?
ACME Laboratories' current E10 is BDT10.32. Overall, ACME Laboratories has a GF Score™ of 82/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ACME Laboratories' E10 compare to ZTS and UTHR?
ACME Laboratories' E10 of BDT10.32 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on ACME Laboratories and its competitors. ACME Laboratories's current E10 is BDT10.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACME Laboratories stock overvalued right now?
Based on GuruFocus' analysis, ACME Laboratories (DHA:ACMELAB) is currently considered Possible Value Trap. The stock's GF Value™ is BDT124.74, compared to a current price of BDT81.60 — trading 34.6% below its estimated fair value. The current E10 is BDT10.32. ACME Laboratories' overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For ACME Laboratories (DHA:ACMELAB), the current E10 is BDT10.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ACME Laboratories (DHA:ACMELAB) Overvalued in 2026?

Based on GuruFocus' analysis, ACME Laboratories stock appears to be undervalued. The current stock price of BDT81.60 is trading 34.6% below its estimated GF Value™ of BDT124.74. GuruFocus considers ACME Laboratories to be Possible Value Trap.

Key valuation signals for DHA:ACMELAB:

  • E10: BDT10.32
  • GF Value™: BDT124.74 vs. price of BDT81.60 (34.6% below fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the DHA:ACMELAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ACME Laboratories Business Description

Address 1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products which includes human drugs comprising dosages form like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, sachet products; veterinary drugs comprising dosages form like bolus, liquid,injection, water-soluble powder, premix and herbal drugs comprising dosages form like liquid, capsule, tablet, cream. The products of the company are sold in domestic and international markets.
82GF Score

Get the complete analysis for DHA:ACMELAB

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT81.60
Price
BDT124.74
GF Value